A
$ Value
$0
Shares
21,500
Price
$0
Filed
Jun 13
Insider
Name
Golumbeski George
Title
—
CIK
0001586660
Roles
Director
Transaction Details
Transaction Date
2025-06-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,500
Footnotes
The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 11, 2026 or the day immediately prior to the 2026 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.
Filing Info
Golumbeski George's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-05 | MURA | D | — |
| 2025-12-05 | MURA | D | — |
| 2025-11-06 | ABOS | A | $0 |
| 2025-07-31 | SAGE | U | — |
| 2025-07-31 | SAGE | D | — |
| 2025-07-31 | SAGE | D | — |
| 2025-07-14 | STTK | A | $0 |
| 2025-06-11 | MURA | A | $0 |
| 2025-06-11 | SAGE | A | $0 |
Other Insiders at SAGE (90d)
No other insider activity at this issuer in the last 90 days.